DCSIMG
9 Property, plant and equipment - Annual Report 2015 - DSM

9 Property, plant and equipment

Table 1

 
Land and
buildings
Plant and
machinery
Other
equip-
ment
Under
construc-
tion
Not used
for operating
activities
Total
Balance at 1 January 2014
           
Cost
2,024
4,441
201
734
20
7,420
Depreciation and impairment losses
844
2,810
140
1
14
3,809
             
Carrying amount
1,180
1,631
61
733
6
3,611
             
Changes in carrying amount:
           
- Capital expenditure
15
43
5
456
-
519
- Put into operation
65
464
18
(547)
-
-
- Acquisitions
15
21
-
-
-
36
- Disposals
(5)
(2)
-
-
-
(7)
- Depreciation
(75)
(285)
(22)
-
-
(382)
- Impairment losses
(11)
(191)
-
(110)
-
(312)
- Exchange differences
60
126
3
34
-
223
- Reclassification to held for sale
(3)
(7)
-
-
-
(10)
- Other reclassifications
(11)
4
8
(7)
-
(6)
- Other changes
-
-
1
-
-
1
             
 
50
173
13
(174)
-
62
Balance at 31 December 2014
           
Cost
2,155
5,097
234
669
20
8,175
Depreciation and impairment losses
925
3,293
160
110
14
4,502
             
Carrying amount
1,230
1,804
74
559
6
3,673
             
Changes in carrying amount:
           
- Capital expenditure
3
31
3
448
-
485
- Put into operation
69
238
15
(322)
-
-
- Acquisitions
32
28
4
1
-
65
- Disposals
(108)
(418)
(10)
(157)
2
(691)
- Depreciation
(74)
(238)
(20)
-
(2)
(334)
- Impairment losses
(12)
(185)
(2)
-
-
(199)
- Impairment reversals
1
-
-
-
-
1
- Exchange differences
53
112
1
17
-
183
- Reclassification to held for sale
(5)
(2)
-
-
-
(7)
- Other reclassifications
(3)
(3)
1
-
-
(5)
             
 
(44)
(437)
(8)
(13)
-
(502)
Balance at 31 December 2015
           
Cost
2,013
3,825
206
547
15
6,606
Depreciation and impairment losses
827
2,458
140
1
9
3,435
             
Carrying amount
1,186
1,367
66
546
6
3,171

There were no material finance lease agreements in 2015 (as was the case in 2014).

In 2015, impairment losses on Property, plant and equipment of €198 million were recognized. This included an impairment of €130 million relating to the disposal of Bulk Chemicals (see note 2 'Change in the scope of consolidation'). Furthermore this included a €19 million impairment of a DSM Dyneema tape production line in the US, primarily used for vehicle protection. At DSM Resins & Functional Materials an impairment of €15 million was taken relating to the factory in Stanley (USA) and €10 million to Property, plant and equipment of DSM-AGI (see also note 6 'Exceptional items').

In 2014, impairment losses on Property, plant and equipment of €312 million were recognized. This mainly related to the impairment of the CGU caprolactam of €291 million at DSM Fibre Intermediates. The impairment test for caprolactam is discussed in note 6 'Exceptional items'.